Archive for May, 2002

FDA Acts To Speed Bioterror Medicines

FDA Acts To Speed Bioterror Medicines Responding to the threat of anthrax and other forms of chemical and biological terrorism, the Food and Drug Administration adopted new rules yesterday that will speed the approval of drugs that could protect people from attacks.


Click here for reuse options!
Copyright 2002 Biotechblog

A Challenge to Science and Nature

A Challenge to Science and Nature A new journal will challenge publishing behemoths such as Science, Nature and Cell by offering free access to research articles immediately upon publication on the Web.


Click here for reuse options!
Copyright 2002 Biotechblog

Cloning Bill Bans Abortion Too?

Cloning Bill Bans Abortion Too? Cloning and abortion — separate issues altogether, right? Maybe not. There are those who believe that if cloning is outlawed, then abortion will be too.


Click here for reuse options!
Copyright 2002 Biotechblog

Biotech Banker Predicts More Meetings But Fewer Attendees

Biotech Banker Predicts More Meetings But Fewer Attendees It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…


Click here for reuse options!
Copyright 2002 Biotechblog

Faulty Genes Explain Why Cloning Is So Difficult

Faulty Genes Explain Why Cloning Is So Difficult Cloning may not always completely reprogram an egg cell the way sexual reproduction does, which would explain why the process fails so often, researchers reported on Monday.


Click here for reuse options!
Copyright 2002 Biotechblog

Two New Bills Present Challenges to DNA Patentability

Two New Bills Present Challenges to DNA Patentability This time the challenge to the patents, commonly called gene patents, comes from the US House of Representatives in the form of two bills introduced on March 15 by Rep. Lynn Rivers (D-Mich.). If enacted, each of these would threaten future biotech innovation in the US.


Click here for reuse options!
Copyright 2002 Biotechblog

Biotech industry's still waiting to break out

Biotech industry’s still waiting to break out It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.


Click here for reuse options!
Copyright 2002 Biotechblog

Biotech industry’s still waiting to break out

Biotech industry’s still waiting to break out It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.


Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: